Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Capodanno D, Mehran R, Krucoff MW, Baber U, Bhatt DL, Capranzano P, Collet JP, Cuisset T, De Luca G, De Luca L, Farb A, Franchi F, Gibson CM, Hahn JY, Hong MK, James S, Kastrati A, Kimura T, Lemos PA, Lopes RD, Magee A, Matsumura R, Mochizuki S, O'Donoghue ML, Pereira NL, Rao SV, Rollini F, Shirai Y, Sibbing D, Smits PC, Steg PG, Storey RF, Ten Berg J, Valgimigli M, Vranckx P, Watanabe H, Windecker S, Serruys PW, Yeh RW, Morice MC, Angiolillo DJ. Capodanno D, et al. Among authors: rollini f. Circulation. 2023 Jun 20;147(25):1933-1944. doi: 10.1161/CIRCULATIONAHA.123.064473. Epub 2023 Jun 19. Circulation. 2023. PMID: 37335828 Review.
[The GRAVITAS study].
Rollini F, Angiolillo DJ, Cattaneo M. Rollini F, et al. G Ital Cardiol (Rome). 2012 Jan;13(1):1-5. doi: 10.1714/1015.11050. G Ital Cardiol (Rome). 2012. PMID: 22322466 Italian. No abstract available.
Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.
Capranzano P, Ferreiro JL, Ueno M, Capodanno D, Dharmashankar K, Darlington A, Desai B, Tello-Montoliu A, Rollini F, Angiolillo DJ. Capranzano P, et al. Among authors: rollini f. Catheter Cardiovasc Interv. 2013 Jan 1;81(1):42-9. doi: 10.1002/ccd.24416. Epub 2012 Apr 17. Catheter Cardiovasc Interv. 2013. PMID: 22431415 Clinical Trial.
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus.
Tello-Montoliu A, Ferreiro JL, Kodali MK, Ueno M, Tomasello SD, Rollini F, Capodanno D, Darlington A, Patel R, Desai B, Guzman LA, Bass TA, Angiolillo DJ. Tello-Montoliu A, et al. Among authors: rollini f. J Thromb Thrombolysis. 2013 Jul;36(1):14-7. doi: 10.1007/s11239-012-0828-1. J Thromb Thrombolysis. 2013. PMID: 23143668 Clinical Trial.
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.
Ferreiro JL, Ueno M, Tello-Montoliu A, Tomasello SD, Capodanno D, Capranzano P, Dharmashankar K, Darlington A, Desai B, Rollini F, Guzman LA, Bass TA, Angiolillo DJ. Ferreiro JL, et al. Among authors: rollini f. J Thromb Thrombolysis. 2013 Feb;35(2):155-64. doi: 10.1007/s11239-012-0846-z. J Thromb Thrombolysis. 2013. PMID: 23184484
Platelet function profiles in patients with diabetes mellitus.
Rollini F, Franchi F, Muñiz-Lozano A, Angiolillo DJ. Rollini F, et al. J Cardiovasc Transl Res. 2013 Jun;6(3):329-45. doi: 10.1007/s12265-013-9449-0. Epub 2013 Feb 13. J Cardiovasc Transl Res. 2013. PMID: 23404189 Review.
123 results